MOLECULAR PATHWAYS IN HEAD AND NECK CANCER: UNRAVELING THE GENETIC, EPIGENETIC, AND ENVIRONMENTAL FACTORS CONTRIBUTING TO TUMOR DEVELOPMENT AND METASTASIS

Abstract

Head-and-neck cancer (HNC), in particular head and neck squamous cell carcinoma (HNSCC type), refers to a heterogeneous malignancy resulting from the convergent and divergent roles played by genetic, epigenetic, and environmental factors. Based on multi-omics analyses in development, recent findings reveal valuable insights about the molecular pathways underlying tumor initiation, progression, and metastasis. This review inspects the key genetic alterations, such as TP53, PIK3CA, and CDKN2A, and epigenetic alterations, including DNA methylation and histone alterations, concerning the tumor microenvironment (TME). An in-depth analysis of the TME is performed, focusing on stroma components, immune cells, and metabolic adjustments support tumor growth and confer resistance to therapy. Understanding these molecular mechanisms will be relevant in the development of precision science approaches aimed at improving the final outcome for the patient. Research on molecular mechanisms of HNSCC development remains essential for creating suitable therapeutic approaches. The tumor's progression as well as its resistance to therapy emerges from the actions of genetic mutations paired with epigenetic changes and TME cellular interactions. The development of precision medicines alongside immunotherapy approaches alongside targeted therapies has created promising new avenues for patient prognostic improvement. Research innovation and cancer biological studies require combined efforts against further issues including tumor heterogeneity alongside therapy resistance. Research findings show that Head and neck cancers (HNCs) create a prominent proportion of worldwide cancer load. The classification of HNSCC stands as the leading form of HNC among its subtypes. These abnormal cell types appear in oral cavity tissues together with those from pharynx and larynx where they demonstrate wide molecular variations and varying clinical behaviors. The pathogenesis of these diseases relies on tobacco use as well as alcohol consumption and infection from particular types of human papillomavirus (HPV). The trio of surgery and radiotherapy and chemotherapy functions as primary treatments for this particular condition yet successful targeted therapies require a deep understanding of tumor development pathways.